Determining the Minimal Clinically Important Difference for 6-Minute Walk Distance in Fibromyalgia.

about

Determining the Minimal Clinically Important Difference for 6-Minute Walk Distance in Fibromyalgia.

Item

http://www.wikidata.org/entity/Q39898535

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Determining the Minimal Clinic ...... Walk Distance in Fibromyalgia.

@en

Determining the Minimal Clinic ...... Walk Distance in Fibromyalgia.

@nl

type

Item

label

Determining the Minimal Clinic ...... Walk Distance in Fibromyalgia.

@en

Determining the Minimal Clinic ...... Walk Distance in Fibromyalgia.

@nl

prefLabel

Determining the Minimal Clinic ...... Walk Distance in Fibromyalgia.

@en

Determining the Minimal Clinic ...... Walk Distance in Fibromyalgia.

@nl

P1476

Determining the Minimal Clinic ...... Walk Distance in Fibromyalgia.

@en

P2093

Anthony S Kaleth

http://www.w3.org/2001/XMLSchema#string

Dennis C Ang

http://www.w3.org/2001/XMLSchema#string

James E Slaven

http://www.w3.org/2001/XMLSchema#string

P2860

Exercise for treating fibromyalgia syndrome

The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference

Pain assessment: global use of the Brief Pain Inventory

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

Research to encourage exercise for fibromyalgia (REEF): use of motivational interviewing, outcomes from a randomized-controlled trial

Psychological treatments for fibromyalgia: a meta-analysis.

The fibromyalgia impact questionnaire: development and validation.

A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain.

ATS statement: guidelines for the six-minute walk test.

A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease.

P304

738-745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PHM.0000000000000485

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27003201

http://www.w3.org/2001/XMLSchema#string

P921

fibromyalgia

P932

5831244

http://www.w3.org/2001/XMLSchema#string